Reaxys use case - Epigen

Epigen Biosciences is a start-up pharmaceutical company that collaborates with academic groups to discover innovative drugs for a range of medical conditions, including renal diseases, cancer and CNS disorders. Co-founder Dr. Fabio Tucci met with Elsevier to discuss how Epigen researchers use Reaxys to support their application of advanced hit-to-lead and lead optimization methods.

Find out how Epigen uses Reaxys intensively for hit identification, hit-to-lead and lead optimization (PDF, 1.2mb).